FDA-cleared blood tests revolutionize Alzheimer's diagnostics
Newly FDA-cleared blood tests from Roche and Fujirebio are set to transform Alzheimer's triaging by offering cheaper, less invasive diagnostic alternatives.
The argument
The reporter discussed how these tests simplify the diagnostic pipeline compared to expensive imaging or invasive spinal taps. While not standalone diagnostics, they are fueling a massive boom in Alzheimer's research and early-stage patient identification.
The thesis, stress-tested
✓ What validates it
- ✓Widespread clinical adoption rates of the Roche and Fujirebio tests
- ✓Insurance coverage approvals for the blood tests
▸ Risks discussed
- ▸Skepticism from some doctors regarding the efficacy of associated amyloid-targeting drugs
- ▸Potential misuse of tests by asymptomatic patients
Hear it yourself
"Even if the Strait opens today completely, it will still take more than fifty days or so from the ship leaving the Strait to actually this crude oil gets refined and get to the end buyer. What we're seeing from traders' analysts is, like, prices are not supposed to go down until third quarter this year, so until roughly September. So it's sorry to say, but I think it's unlikely that we'll see gas prices drop back to a pre war level in July. That was WSJ Energy Markets reporter, Rebecca Fing. Optimism about the agreement with Iran drove oil prices to their lowest point since March."
06:10
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE